Tonix Pharmaceuticals Holding, based in Chatham, New Jersey, specializes in developing therapeutics for CNS disorders and immunology, with a portfolio including TNX-102 SL for fibromyalgia and TNX-1500 for autoimmune diseases. Founded in 2010, the company employs 103 people and markets Zembrace SymTouch and Tosymra.
Carolyn E Taylor bought 418 shares of TNXP on 21 August at $36.03 per share, worth a total of $15K. They now own 418 TNXP shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
